miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 7, Pages e2958
Publisher
Springer Nature
Online
2017-07-27
DOI
10.1038/cddis.2017.300
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Update on Hereditary Colorectal Cancer
- (2016) FELIPE CARNEIRO DA SILVA et al. ANTICANCER RESEARCH
- CRY2 and FBXL3 Cooperatively Degrade c-MYC
- (2016) Anne-Laure Huber et al. MOLECULAR CELL
- Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer
- (2016) F Graziano et al. PHARMACOGENOMICS JOURNAL
- Multisciplinary management of patients with liver metastasis from colorectal cancer
- (2016) Kathleen De Greef et al. WORLD JOURNAL OF GASTROENTEROLOGY
- miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth
- (2016) Yan-Yan Jia et al. Oncotarget
- MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis
- (2015) Keun Hur BMB Reports
- PML/RAR -Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia
- (2015) D. Brauer-Hartmann et al. CANCER RESEARCH
- Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma
- (2015) Zeynep F. Karagonlar et al. DRUG DEVELOPMENT RESEARCH
- Warburg effect regulated by amphiregulin in the development of colorectal cancer
- (2015) Sung Ouk Nam et al. Cancer Medicine
- The interplay between histone deacetylases and c-Myc in the transcriptional suppression of HPP1 in colon cancer
- (2014) Jian Wang et al. CANCER BIOLOGY & THERAPY
- miR-181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathway
- (2014) Zhonghua Wei et al. FEBS LETTERS
- Is Cancer a Metabolic Disease?
- (2013) Hilary A. Coller AMERICAN JOURNAL OF PATHOLOGY
- Regulation and function of pyruvate kinase M2 in cancer
- (2013) Weiwei Yang et al. CANCER LETTERS
- Tumor glycolysis as a target for cancer therapy: progress and prospects
- (2013) Shanmugasundaram Ganapathy-Kanniappan et al. Molecular Cancer
- How does cancer cell metabolism affect tumor migration and invasion?
- (2013) Tianyu Han et al. Cell Adhesion & Migration
- Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases
- (2012) Eliza A Hawkes et al. BMC CANCER
- Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells
- (2012) Cheng-Fu Zhou et al. IUBMB LIFE
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
- (2011) Sophia Y. Lunt et al. Annual Review of Cell and Developmental Biology
- Cancer as a metabolic disease
- (2010) Thomas N Seyfried et al. Nutrition & Metabolism
- Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
- (2010) A. Le et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clock Genes and Cancer
- (2009) Patricia A. Wood et al. INTEGRATIVE CANCER THERAPIES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search